Literature DB >> 20228305

Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Gerald Konrad1.   

Abstract

OBJECTIVE: To determine whether dietary restrictions enhance the specificity of guaiac-based fecal occult blood tests (FOBTs) when screening for colorectal cancer. DATA SOURCES: PubMed-MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, and Cochrane databases were searched. STUDY SELECTION: English-language case series, cohort studies, randomized controlled trials (RCTs), and meta-analyses were selected. Studies that did not include dietary manipulation or the use of guaiac-based FOBTs available in North America were excluded. SYNTHESIS: Ten case series, 5 cohort studies, 4 RCTs, and 1 meta-analysis were critically appraised. All studies used Hemoccult, Hemoccult II, or Hemoccult SENSA tests. Data from case series involving challenge diets showed no increase in positive FOBT results from high-peroxidase vegetables, but results varied with red-meat challenges depending on the amount of meat consumed and the test used. Case series, cohort studies, and RCTs comparing FOBT results during restricted versus unrestricted diets consistently showed no differences in positive FOBT results.
CONCLUSION: Most of the evidence evaluating the effect of dietary restrictions on FOBT results is dated and of suboptimal quality. However, 4 RCTs and a meta-analysis of these data do not support dietary restrictions when screening for colorectal cancer. Because patient adherence can be an issue with FOBTs, and dietary restrictions can affect adherence in some populations, it is reasonable to abandon these recommendations without fear of substantially affecting specificity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228305      PMCID: PMC2837686     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  25 in total

1.  Meta-analysis of dietary restriction during fecal occult blood testing.

Authors:  M Pignone; M K Campbell; C Carr; C Phillips
Journal:  Eff Clin Pract       Date:  2001 Jul-Aug

2.  Occult blood testing for detection of asymptomatic colon cancer.

Authors:  D H Greegor
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

3.  [Does rehydration improve hemoccult screening for intestinal cancer?].

Authors:  P H Hammes; R Gnauck
Journal:  Z Gastroenterol       Date:  1985-12       Impact factor: 2.000

4.  False positive and negative hemoccult reactions on a normal diet and effect of diet restriction.

Authors:  M L Bassett; K J Goulston
Journal:  Aust N Z J Med       Date:  1980-02

5.  Optimal dietary conditions for hemoccult testing.

Authors:  F A Macrae; D J St John; P Caligiore; L S Taylor; J W Legge
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

6.  False-positive Hemoccult test not caused by turnips.

Authors:  G T Broderick; S M Harris
Journal:  N Engl J Med       Date:  1982-07-15       Impact factor: 91.245

7.  Effect of diet on fecal occult blood testing in patients with colorectal polyps.

Authors:  R G Norfleet
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

8.  Hemoccult screening in selected patients.

Authors:  P B Daron; L I Goldman
Journal:  South Med J       Date:  1981-06       Impact factor: 0.954

9.  Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.

Authors:  Linda Rabeneck; Caroline Zwaal; Joel Hartley Goodman; Verna Mai; Mo Zamkanei
Journal:  Clin Biochem       Date:  2008-08-29       Impact factor: 3.281

10.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

View more
  10 in total

1.  Use of fecal occult blood testing in hospitalized patients: results of an audit.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Lisa Kaita; Claudia Ruiz; Elaine McIntyre; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

Review 2.  Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 3.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

4.  Educational Case: Hereditary Colorectal Cancer and Association With Endometrial Carcinoma.

Authors:  Wendy Z Lim; Zachary A Hemann; Walter L Kemp
Journal:  Acad Pathol       Date:  2021-07-27

Review 5.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

6.  Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Al Buchel; Debrah Wirtzfeld; Gerald Konrad; Tunji Fatoye; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

Review 7.  Colorectal cancer screening: tests, strategies, and perspectives.

Authors:  Fabrizio Stracci; Manuel Zorzi; Grazia Grazzini
Journal:  Front Public Health       Date:  2014-10-27

8.  A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.

Authors:  Anita Annaházi; Szabolcs Ábrahám; Klaudia Farkas; András Rosztóczy; Orsolya Inczefi; Imre Földesi; Mónika Szűcs; Mariann Rutka; Vassilia Theodorou; Helene Eutamene; Lionel Bueno; György Lázár; Tibor Wittmann; Tamás Molnár; Richárd Róka
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

9.  High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.

Authors:  Jeremy P Brown; Kate Wooldrage; Suzanne Wright; Claire Nickerson; Amanda J Cross; Wendy S Atkin
Journal:  J Med Screen       Date:  2017-05-03       Impact factor: 2.136

10.  Evaluation of the guaiac fecal occult blood test for detection of gastrointestinal bleeding in the rhesus macaque (Macaca mulatta).

Authors:  Rachel Elizabeth Cooper; Eric Kenneth Hutchinson; Jessica Marie Izzi
Journal:  J Med Primatol       Date:  2019-11-01       Impact factor: 0.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.